Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma

Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over the last three years. Because...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Robin Park, Fariha Eshrat, Mohammed Al-Jumayli, Azhar Saeed, Anwaar Saeed
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2020-08-01
Serie:Vaccines
Soggetti:
hepatocellular carcinoma
PD-L1
CTLA-4
oncolytic viruses
antigen peptide vaccines
DC vaccines
Accesso online:https://www.mdpi.com/2076-393X/8/3/447
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi